Skip to content
sellWeak

Kerr Holbrook sold $165k of AVNS

SVP, Chief Commercial Officer at AVANOS MEDICAL, INC.. 15,000 shares at an average of $11.00, traded Nov 18, 2025, filed Nov 19, 2025.

Warning score
31
Value
$165k
15,000 shares
Holdings after
83,860
-15% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $165k at market
    +11
  • Share of holdings sold
    Sold 15% of holdings
    +5
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001606498-25-000133, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2025SOpen-market sale
Common Stock
-13,834$11.00$152k85,026Nov 19, 2025
Nov 18, 2025SOpen-market sale
Common Stock
-100$11.01$1,10184,926Nov 19, 2025
Nov 18, 2025SOpen-market sale
Common Stock
-761$11.01$8,37984,165Nov 19, 2025
Nov 18, 2025SOpen-market sale
Common Stock
-305$11.02$3,36183,860Nov 19, 2025

Related signals

Other insiders at AVANOS MEDICAL, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
45Moderate
AVNSbuy
AVANOS MEDICAL, INC.
Gary Blackford
director
$659k
60,000 shares
+84%
25Weak
AVNSsell
AVANOS MEDICAL, INC.
Kerr Holbrook
SVP, Chief Commercial Officer
$107k
7,000 shares
-8%
33Weak
AVNSsell
AVANOS MEDICAL, INC.
Michael Greiner
SVP - Chief Financial Officer
$153k
8,000 shares
-5%
15Weak
AVNSbuy
AVANOS MEDICAL, INC.
Julie Ann Shimer
director
$9,925
500 shares
+1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kerr Holbrook sold $165k of AVNS | InsiderTell